Literature DB >> 18328258

MESOMARK kit detects C-ERC/mesothelin, but not SMRP with C-terminus.

Tatsuya Segawa1, Yoshiaki Hagiwara, Kiyoshi Ishikawa, Naoko Aoki, Masahiro Maeda, Kazu Shiomi, Okio Hino.   

Abstract

ERC/mesothelin is expressed on the normal mesothelium and some cancers such as mesothelioma or ovarian carcinoma. A splicing isoform of ERC/mesothelin (known as SMRP), which has an 82-bp insertion and codes for a C-terminus with a hydrophilic, presumably soluble, tail instead of a GPI-anchoring signal, has been reported as a useful marker for the diagnosis of mesothelioma. However, the existence of SMRP has not yet been demonstrated in the serum of mesothelioma patients. To elucidate the existence of SMRP, we have established a new enzyme-linked immunosorbent assay (ELISA) system for SMRP. The ELISA study revealed that N- and C-ERC/mesothelin were detected in sera from mesothelioma patients, but not SMRP, even in these samples. This result showed that the SMRP detected with MESOMARK kit should be lack of soluble C-terminus and indistinguishable from C-ERC/mesothelin. Further study might be necessary to demonstrate the relationship between SMRP and mesothelin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18328258     DOI: 10.1016/j.bbrc.2008.02.114

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.

Authors:  Ingegerd Hellstrom; Karl Erik Hellstrom
Journal:  Expert Opin Med Diagn       Date:  2011-05-01

2.  Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.

Authors:  S Tsuji; Y Tsuura; T Morohoshi; T Shinohara; F Oshita; K Yamada; Y Kameda; T Ohtsu; Y Nakamura; Y Miyagi
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

3.  Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target.

Authors:  Stefania Crispi; Raffaele A Calogero; Mario Santini; Pasquale Mellone; Bruno Vincenzi; Gennaro Citro; Giovanni Vicidomini; Silvia Fasano; Rosaria Meccariello; Gilda Cobellis; Simona Menegozzo; Riccardo Pierantoni; Francesco Facciolo; Alfonso Baldi; Massimo Menegozzo
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.